These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 26905044)

  • 21. ECNP consensus meeting. Bipolar depression. Nice, March 2007.
    Goodwin GM; Anderson I; Arango C; Bowden CL; Henry C; Mitchell PB; Nolen WA; Vieta E; Wittchen HU
    Eur Neuropsychopharmacol; 2008 Jul; 18(7):535-49. PubMed ID: 18501566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of Desvenlafaxine Compared With Placebo in Major Depressive Disorder Patients by Age Group and Severity of Depression at Baseline.
    Mosca D; Zhang M; Prieto R; Boucher M
    J Clin Psychopharmacol; 2017 Apr; 37(2):182-192. PubMed ID: 28146000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quetiapine Extended Release Open-Label Treatment Associated Changes in Amygdala Activation and Connectivity in Anxious Depression: An fMRI Study.
    Altinay M; Karne H; Beall E; Anand A
    J Clin Psychopharmacol; 2016 Dec; 36(6):562-571. PubMed ID: 27768670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Study of socio-demographic factors in the treatment of unipolar major depression in a follow-up clinical trial].
    Ferencz M; Csibi S; Gabos Grecu J
    Orv Hetil; 2017 Oct; 158(43):1715-1722. PubMed ID: 29135294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A spirituality teaching program for depression: a randomized controlled trial.
    Rickhi B; Moritz S; Reesal R; Xu TJ; Paccagnan P; Urbanska B; Liu MF; Ewing H; Toews J; Gordon J; Quan H
    Int J Psychiatry Med; 2011; 42(3):315-29. PubMed ID: 22439299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies.
    Tourian KA; Padmanabhan SK; Groark J; Brisard C; Farrington D
    Clin Ther; 2009 Jun; 31 Pt 1():1405-23. PubMed ID: 19698901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluoxetine treatment of depressed patients with comorbid anxiety disorders.
    Sonawalla SB; Farabaugh A; Johnson MW; Morray M; Delgado ML; Pingol MG; Rosenbaum JF; Fava M
    J Psychopharmacol; 2002 Sep; 16(3):215-9. PubMed ID: 12236627
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Life review therapy for older adults with moderate depressive symptomatology: a pragmatic randomized controlled trial.
    Korte J; Bohlmeijer ET; Cappeliez P; Smit F; Westerhof GJ
    Psychol Med; 2012 Jun; 42(6):1163-73. PubMed ID: 21995889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emotional withdrawal, CT abnormalities and drug response in late life depression.
    Altamura AC; Bassetti R; Santini A; Frisoni GB; Mundo E
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):349-54. PubMed ID: 14751432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trajectories of Change in a Group Behavioral Activation Treatment for Severe, Recurrent Depression.
    O'Mahen HA; Moberly NJ; Wright KA
    Behav Ther; 2019 May; 50(3):504-514. PubMed ID: 31030869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
    Alpert JE; Franznick DA; Hollander SB; Fava M
    J Clin Psychiatry; 2004 Aug; 65(8):1069-75. PubMed ID: 15323591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study.
    Lin CH; Lin SH; Jang FL
    J Clin Psychopharmacol; 2011 Oct; 31(5):563-8. PubMed ID: 21869699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of older adults with co-morbid personality disorder and depression: a dialectical behavior therapy approach.
    Lynch TR; Cheavens JS; Cukrowicz KC; Thorp SR; Bronner L; Beyer J
    Int J Geriatr Psychiatry; 2007 Feb; 22(2):131-43. PubMed ID: 17096462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Behavioral activation for late adolescents with subthreshold depression: a randomized controlled trial.
    Takagaki K; Okamoto Y; Jinnin R; Mori A; Nishiyama Y; Yamamura T; Yokoyama S; Shiota S; Okamoto Y; Miyake Y; Ogata A; Kunisato Y; Shimoda H; Kawakami N; Furukawa TA; Yamawaki S
    Eur Child Adolesc Psychiatry; 2016 Nov; 25(11):1171-1182. PubMed ID: 27003390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized, controlled trial with 6-month follow-up of repetitive transcranial magnetic stimulation and electroconvulsive therapy for severe depression.
    Eranti S; Mogg A; Pluck G; Landau S; Purvis R; Brown RG; Howard R; Knapp M; Philpot M; Rabe-Hesketh S; Romeo R; Rothwell J; Edwards D; McLoughlin DM
    Am J Psychiatry; 2007 Jan; 164(1):73-81. PubMed ID: 17202547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in energy during treatment of depression: an analysis of duloxetine in double-blind placebo-controlled trials.
    Harada E; Kato M; Fujikoshi S; Wohlreich MM; Berggren L; Tokuoka H
    Int J Clin Pract; 2015 Oct; 69(10):1139-48. PubMed ID: 25980552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Empirically derived decision trees for the treatment of late-life depression.
    Andreescu C; Mulsant BH; Houck PR; Whyte EM; Mazumdar S; Dombrovski AY; Pollock BG; Reynolds CF
    Am J Psychiatry; 2008 Jul; 165(7):855-62. PubMed ID: 18450930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: a randomized, parallel group, open-label trial.
    Amsterdam JD; Wang CH; Shwarz M; Shults J
    J Affect Disord; 2009 Jan; 112(1-3):219-30. PubMed ID: 18486235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacotherapy plus psychotherapy for treatment of depression in active injection drug users.
    Stein MD; Solomon DA; Herman DS; Anthony JL; Ramsey SE; Anderson BJ; Miller IW
    Arch Gen Psychiatry; 2004 Feb; 61(2):152-9. PubMed ID: 14757591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bipolar II vs. unipolar depression: psychopathologic differentiation by dimensional measures.
    Hantouche EG; Akiskal HS
    J Affect Disord; 2005 Feb; 84(2-3):127-32. PubMed ID: 15708409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.